Filing Details
- Accession Number:
- 0001104659-21-002983
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-11 16:26:49
- Reporting Period:
- 2021-01-08
- Accepted Time:
- 2021-01-11 16:26:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1613859 | Pra Health Sciences Inc. | PRAH | Services-Commercial Physical & Biological Research (8731) | 463640387 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1624044 | L Christopher Gaenzle | C/O Pra Health Sciences, Inc. 4130 Parklake Avenue, Suite 400 Raleigh NC 27612 | Evp, Cao & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-01-08 | 3,136 | $130.04 | 34,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $130.00 to $130.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.